- Home
- MBI vs TSHA Comparison
MBI vs TSHA Comparison
Compare MBI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- TSHA
- Stock Information
- Founded
- MBI 1973
- TSHA 2019
- Country
- MBI United States
- TSHA United States
- Employees
- MBI N/A
- TSHA N/A
- Industry
- MBI Property-Casualty Insurers
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- TSHA Health Care
- Exchange
- MBI Nasdaq
- TSHA Nasdaq
- Market Cap
- MBI 311.3M
- TSHA 334.1M
- IPO Year
- MBI 1987
- TSHA 2020
- Fundamental
- Price
- MBI $5.41
- TSHA $1.72
- Analyst Decision
- MBI Buy
- TSHA Strong Buy
- Analyst Count
- MBI 2
- TSHA 8
- Target Price
- MBI $6.75
- TSHA $6.63
- AVG Volume (30 Days)
- MBI 452.6K
- TSHA 1.6M
- Earning Date
- MBI 05-08-2025
- TSHA 02-26-2025
- Dividend Yield
- MBI N/A
- TSHA N/A
- EPS Growth
- MBI N/A
- TSHA N/A
- EPS
- MBI N/A
- TSHA N/A
- Revenue
- MBI $27,000,000.00
- TSHA $8,333,000.00
- Revenue This Year
- MBI N/A
- TSHA N/A
- Revenue Next Year
- MBI N/A
- TSHA N/A
- P/E Ratio
- MBI N/A
- TSHA N/A
- Revenue Growth
- MBI 285.71
- TSHA N/A
- 52 Week Low
- MBI $3.22
- TSHA $1.19
- 52 Week High
- MBI $7.46
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- MBI 37.63
- TSHA 54.32
- Support Level
- MBI $4.93
- TSHA $1.66
- Resistance Level
- MBI $5.67
- TSHA $1.79
- Average True Range (ATR)
- MBI 0.42
- TSHA 0.11
- MACD
- MBI -0.11
- TSHA 0.01
- Stochastic Oscillator
- MBI 20.08
- TSHA 47.62
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and by mutual funds. It operates in three segments: the United States public finance insurance, corporate, and international & structured finance insurance. U.S. public finance insurance portfolio is managed through National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.